CIK 0001093557 · Large accelerated filer
DEXCOM INC
Sign in to watch- Ticker
- DXCM
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330857544
- Phone
- 8582000200
- Business address
- 6340 SEQUENCE DRIVE, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,328,435
- in 8 filings, $4.3M under 10b5-1 plans
Net −$4,328,435. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- SAYER KEVIN R −$2.4M Executive Chair sold 8% of stake
- AUGUSTINOS NICHOLAS −$680K Director sold 22% of stake
- Stern Sadie −$649K EVP Chief People & Culture Off sold 6% of stake
- Sylvain Jereme M −$303K EVP, Chief Financal Officer sold 2% of stake
- Brown Michael Jon −$288K EVP Chief Legal Compliance Off sold 3% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-09-09 | Selvaraj Shelly Ramasamy SVP Information Technology | Sale | −241 | $550.63 | $133K | 13,695 |
| 2021-09-09 | Balo Andrew K * | Other disposition | −2,498 | 14,056 | ||
| 2021-09-09 | Balo Andrew K * | Other acquisition | +2,498 | 13,150 | ||
| 2021-09-09 | Balo Andrew K * | Sale | −1,248 | $541.36 | $676K | 11,902 |
| 2021-09-09 | Balo Andrew K * | Sale | −15 | $541.76 | $8K | 11,887 |
| 2021-09-09 | Balo Andrew K * | Sale | −273 | $541.33 | $148K | 11,614 |
| 2021-09-09 | Balo Andrew K * | Sale | −200 | $542.83 | $109K | 11,414 |
| 2021-09-09 | Balo Andrew K * | Sale | −50 | $543.66 | $27K | 11,364 |
| 2021-09-09 | Balo Andrew K * | Sale | −550 | $547.35 | $301K | 10,814 |
| 2021-09-09 | Balo Andrew K * | Sale | −750 | $548.24 | $411K | 10,064 |
| 2021-09-09 | Balo Andrew K * | Sale | −1,261 | $549.43 | $693K | 8,803 |
| 2021-09-09 | Balo Andrew K * | Sale | −1,200 | $550.36 | $660K | 7,603 |
| 2021-09-09 | Balo Andrew K * | Sale | −50 | $551.45 | $28K | 7,553 |
| 2021-09-09 | Sylvain Jereme M EVP, Chief Financial Officer | Sale | −402 | $541.36 | $218K | 13,531 |
| 2021-09-09 | Sylvain Jereme M EVP, Chief Financial Officer | Sale | −5 | $541.76 | $3K | 13,526 |
| 2021-09-09 | Shrishrimal Sumi SVP Chief Risk Officer | Sale | −402 | $541.36 | $218K | 12,239 |
| 2021-09-09 | Shrishrimal Sumi SVP Chief Risk Officer | Sale | −5 | $542.46 | $3K | 12,234 |
| 2021-09-09 | SAYER KEVIN R Chairman, CEO & President | Sale | −35 | $541.27 | $19K | 105,687 |
| 2021-09-09 | SAYER KEVIN R Chairman, CEO & President | Sale | −2,982 | $541.36 | $1.6M | 102,705 |
| 2021-09-09 | Patterson Chad EVP, Global Marketing | Sale | −287 | $541.36 | $155K | 9,904 |
Page 33 of 40 · 785 trades